This study examined a combination of dendritic cell (DC) therapy and cytokine-induced killer (CIK) cells with high-dose chemotherapy (HDC) for metastatic breast cancer (MBC) patients.
Selections of appropriate regimen of high-dose chemotherapy combined with adoptive cellular therapy with dendritic and cytokine-induced killer cells improved progression-free and overall survival in patients with metastatic breast cancer
Autologous Dendritic Cell-Cytokine Induced Killer Cell Immunotherapy Combined with S-1 Plus Cisplatin in Patients with Advanced Gastric Cancer: A Prospective Study
Adjuvant treatment for triple-negative breast cancer: a retrospective study of immunotherapy with autologous cytokine- induced killer cells in 294 patients
